Skip to main content
Top
Published in: Urolithiasis 3/2010

01-06-2010 | Original Paper

Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects

Authors: Joseph Okombo, Michael Liebman

Published in: Urolithiasis | Issue 3/2010

Login to get access

Abstract

Both a high dietary oxalate intake and increased intestinal absorption appear to be major causes of elevated urine oxalate, a risk factor for kidney stone formation. By favorably altering the gastrointestinal bacterial population, probiotics have the potential to lower oxalate absorption/urinary excretion. This study assessed whether a 4-wk daily consumption of a commercially available probiotic by 11 healthy volunteers (8 females, 3 males), aged 21-36 y, would decrease oxalate absorption. The study involved the ingestion of a probiotic (VSL#3®) for a 4 wk period followed by a 4 wk washout period. Oxalate load tests, providing a total of 80 mg oxalate, were conducted at baseline (pre-probiotic), and after the probiotic and washout periods. In the total subject population, mean total 22 h oxalate absorption at baseline (30.8 %) was significantly higher than after the probiotic (11.6 %) and washout (11.5 %) periods. However, four subjects identified as high oxalate absorbers at baseline had a particularly marked probiotic-induced reduction in oxalate absorption, which largely accounted for the reduction observed in the total subject population. The overall data suggested that in individuals characterized by high oxalate absorption levels, VSL#3® ingestion has the potential to reduce gastrointestinal oxalate absorption, which could decrease risk of kidney stones and other disorders related to hyperoxaluria.
Literature
1.
go back to reference Hatch M, Freel RW (1995) Alterations in intestinal transport oxalate in disease states. Scanning Microsc 9:1121–1126PubMed Hatch M, Freel RW (1995) Alterations in intestinal transport oxalate in disease states. Scanning Microsc 9:1121–1126PubMed
2.
go back to reference Noonan SC, Savage GP (1999) Oxalate content of foods and its effect on human. Asia Pac J Clin Nutr 8:64–74CrossRef Noonan SC, Savage GP (1999) Oxalate content of foods and its effect on human. Asia Pac J Clin Nutr 8:64–74CrossRef
3.
go back to reference Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT (1979) Renal stone epidemiology: A 25-year study in Rochester, Minnesota. Kidney Int 16:624–631CrossRefPubMed Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT (1979) Renal stone epidemiology: A 25-year study in Rochester, Minnesota. Kidney Int 16:624–631CrossRefPubMed
4.
go back to reference Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276CrossRefPubMed Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276CrossRefPubMed
5.
go back to reference Binder HJ (1974) Intestinal oxalate absorption. Gastroenterology 67:441–446PubMed Binder HJ (1974) Intestinal oxalate absorption. Gastroenterology 67:441–446PubMed
6.
8.
go back to reference Prenen JA, Boer P, Mees EJ (1984) Absorption kinetics of oxalate from oxalate-rich food in man. Am J Clin Nutr 40:1007–1010PubMed Prenen JA, Boer P, Mees EJ (1984) Absorption kinetics of oxalate from oxalate-rich food in man. Am J Clin Nutr 40:1007–1010PubMed
9.
go back to reference Holmes RP, Ambrosius WT, Assimos DG (2005) Dietary oxalate loads and renal oxalate handling. J Urol 174:943–947CrossRefPubMed Holmes RP, Ambrosius WT, Assimos DG (2005) Dietary oxalate loads and renal oxalate handling. J Urol 174:943–947CrossRefPubMed
10.
go back to reference Hatch M, Freel RW, Vaziri ND (1993) Characteristics of the transport of oxalate and other ions across rabbit proximal colon. Pflugers Arch 423:206–212CrossRefPubMed Hatch M, Freel RW, Vaziri ND (1993) Characteristics of the transport of oxalate and other ions across rabbit proximal colon. Pflugers Arch 423:206–212CrossRefPubMed
11.
go back to reference Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scanning Microsc 9:1109–1120PubMed Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scanning Microsc 9:1109–1120PubMed
12.
go back to reference Chai W, Liebman M, Kynast-Gales S, Massey L (2004) Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis 44:1060–1069CrossRefPubMed Chai W, Liebman M, Kynast-Gales S, Massey L (2004) Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. Am J Kidney Dis 44:1060–1069CrossRefPubMed
13.
go back to reference Krishnamurthy MS, Hruska KA, Chandhoke PS (2003) The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol 169:2030–2033CrossRefPubMed Krishnamurthy MS, Hruska KA, Chandhoke PS (2003) The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol 169:2030–2033CrossRefPubMed
14.
go back to reference Stauffer JQ (1977) Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Dig Dis Sci 22:921–928CrossRef Stauffer JQ (1977) Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Dig Dis Sci 22:921–928CrossRef
15.
go back to reference Hess B (1996) Low calcium diet in hypercalciuric calcium nephrolithiasis patients: first do no harm. Scanning Microsc 10:547–554PubMed Hess B (1996) Low calcium diet in hypercalciuric calcium nephrolithiasis patients: first do no harm. Scanning Microsc 10:547–554PubMed
16.
go back to reference Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110CrossRefPubMed Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110CrossRefPubMed
17.
go back to reference Ouwehand AC, Salminen S, Isolauri E (2002) Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 82:279–289CrossRefPubMed Ouwehand AC, Salminen S, Isolauri E (2002) Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 82:279–289CrossRefPubMed
18.
go back to reference Ito H, Miura N, Masai M et al (1996) Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1. Int J Urol 3:31–34CrossRefPubMed Ito H, Miura N, Masai M et al (1996) Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1. Int J Urol 3:31–34CrossRefPubMed
19.
go back to reference Hokama S, Honma Y, Toma C, Ogawa Y (2000) Oxalate-degrading Enterococcus faecalis. Microbiol Immunol 44:235–240PubMed Hokama S, Honma Y, Toma C, Ogawa Y (2000) Oxalate-degrading Enterococcus faecalis. Microbiol Immunol 44:235–240PubMed
20.
go back to reference Weese JS, Weese HE, Yuricek L, Rousseau J (2004) Oxalate degradation by intestinal lactic acid bacteria in dogs and cats. Vet Microbiol 101:161–166CrossRefPubMed Weese JS, Weese HE, Yuricek L, Rousseau J (2004) Oxalate degradation by intestinal lactic acid bacteria in dogs and cats. Vet Microbiol 101:161–166CrossRefPubMed
21.
go back to reference Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart C (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847CrossRefPubMed Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart C (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841–3847CrossRefPubMed
22.
go back to reference Gilliland SE (1990) Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev 87:175–188CrossRef Gilliland SE (1990) Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev 87:175–188CrossRef
23.
go back to reference Azcarate-Peril MA, Bruno-Ba′rcena JM, Hassan HM, Klaenhammer TR (2006) Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. App Environ Microbiol 72:1891–1899CrossRef Azcarate-Peril MA, Bruno-Ba′rcena JM, Hassan HM, Klaenhammer TR (2006) Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. App Environ Microbiol 72:1891–1899CrossRef
24.
go back to reference Lewanika TR, Reid SJ, Abratt VR, Macfarlane GT, Macfarlane S (2007) Lactobacillus gasseri Gasser AM63T degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota. FEMS Microbiol Ecol 61:110–120CrossRefPubMed Lewanika TR, Reid SJ, Abratt VR, Macfarlane GT, Macfarlane S (2007) Lactobacillus gasseri Gasser AM63T degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota. FEMS Microbiol Ecol 61:110–120CrossRefPubMed
25.
go back to reference Federici F, Vitali B, Gotti R, Pasca MR, Gobbi S, Peck AB, Brigidi P (2004) Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl Environ Microbiol 70:5066–5073CrossRefPubMed Federici F, Vitali B, Gotti R, Pasca MR, Gobbi S, Peck AB, Brigidi P (2004) Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl Environ Microbiol 70:5066–5073CrossRefPubMed
26.
go back to reference Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S et al (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105CrossRefPubMed Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S et al (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105CrossRefPubMed
27.
go back to reference Lieske JC, Goldfarb DS, DeSimone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244–1249CrossRefPubMed Lieske JC, Goldfarb DS, DeSimone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244–1249CrossRefPubMed
28.
go back to reference Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–147CrossRefPubMed Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–147CrossRefPubMed
29.
go back to reference Tang M, Larson-Meyer DE, Liebman M (2008) Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr 87:1262–1267PubMed Tang M, Larson-Meyer DE, Liebman M (2008) Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr 87:1262–1267PubMed
30.
go back to reference Li MG, Madappally MM (1989) Rapid enzymatic determination of urinary oxalate. Clin Chem 35:2330–2333PubMed Li MG, Madappally MM (1989) Rapid enzymatic determination of urinary oxalate. Clin Chem 35:2330–2333PubMed
31.
go back to reference Lustgarten JA, Wenk RE (1972) Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–1422PubMed Lustgarten JA, Wenk RE (1972) Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–1422PubMed
32.
go back to reference Goldfarb DS (2004) Microorganisms and calcium oxalate disease. Nephron Physiol 98:48–54CrossRef Goldfarb DS (2004) Microorganisms and calcium oxalate disease. Nephron Physiol 98:48–54CrossRef
33.
go back to reference Turroni S, Vitali B, Bendazzoli C, Candela M, Gotti R, Federici F, Pirovano F, Brigidi P (2007) Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA transferase activity in Lactobacilli acidophilus. J Appl Microbiol 103:1600–1609CrossRefPubMed Turroni S, Vitali B, Bendazzoli C, Candela M, Gotti R, Federici F, Pirovano F, Brigidi P (2007) Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA transferase activity in Lactobacilli acidophilus. J Appl Microbiol 103:1600–1609CrossRefPubMed
34.
go back to reference Bibiloni R, Fedorak RN, Tannok GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB (2005) VSL#3® probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100:1539–1546CrossRefPubMed Bibiloni R, Fedorak RN, Tannok GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB (2005) VSL#3® probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100:1539–1546CrossRefPubMed
35.
go back to reference Kim HJ, Vazquez R, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR (2005) A randomized controlled trial of a probiotic combination VSL#3® and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 17:1–10CrossRef Kim HJ, Vazquez R, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR (2005) A randomized controlled trial of a probiotic combination VSL#3® and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 17:1–10CrossRef
36.
go back to reference Holmes RP, Assimos DG (2004) The impact of dietary oxalate on kidney stone formation. Urol Res 32:311–316CrossRefPubMed Holmes RP, Assimos DG (2004) The impact of dietary oxalate on kidney stone formation. Urol Res 32:311–316CrossRefPubMed
37.
go back to reference Grentz L, Massey LK (2002) Contribution of dietary oxalate to urinary oxalate in health and disease. Top Clin Nutr 17:60–70 Grentz L, Massey LK (2002) Contribution of dietary oxalate to urinary oxalate in health and disease. Top Clin Nutr 17:60–70
38.
go back to reference Brigidi P, Swennen E, Vitali B, Rossi M, Matteuzzi D (2003) PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. Int J Food Microbiol 81:203–209CrossRefPubMed Brigidi P, Swennen E, Vitali B, Rossi M, Matteuzzi D (2003) PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. Int J Food Microbiol 81:203–209CrossRefPubMed
39.
go back to reference Dobbins JW, Binder HJ (1977) Importance of the colon in enteric hyperoxaluria. New Engl J Med 296:298–301PubMedCrossRef Dobbins JW, Binder HJ (1977) Importance of the colon in enteric hyperoxaluria. New Engl J Med 296:298–301PubMedCrossRef
40.
go back to reference Modigliani R, Labayle D, Aymes C, Denvil R (1978) Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria. Scand J Gastroenterol 13:187–192CrossRefPubMed Modigliani R, Labayle D, Aymes C, Denvil R (1978) Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria. Scand J Gastroenterol 13:187–192CrossRefPubMed
41.
go back to reference von Unruh GE, Bell AE, Hesse A (2007) Effect of oxalate test dose size on absolute and percent oxalate absorption. Isotopes in Environ Health Stud 42:107–112CrossRef von Unruh GE, Bell AE, Hesse A (2007) Effect of oxalate test dose size on absolute and percent oxalate absorption. Isotopes in Environ Health Stud 42:107–112CrossRef
42.
go back to reference von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2] oxalate absorption test. J Urol 169:687–690CrossRef von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2] oxalate absorption test. J Urol 169:687–690CrossRef
43.
go back to reference Knight J, Holmes RP, Assimos DG (2007) Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res 35:111–117CrossRefPubMed Knight J, Holmes RP, Assimos DG (2007) Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res 35:111–117CrossRefPubMed
44.
go back to reference Hatch M, Freel RW, Vaziri ND (1994) Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 5:1339–1343PubMed Hatch M, Freel RW, Vaziri ND (1994) Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 5:1339–1343PubMed
45.
go back to reference Goldfarb SD, Modersitzki F, Asplin JR (2007) A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2:745–749CrossRefPubMed Goldfarb SD, Modersitzki F, Asplin JR (2007) A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2:745–749CrossRefPubMed
46.
go back to reference Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV (1986) Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116:455–460PubMed Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV (1986) Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116:455–460PubMed
47.
go back to reference Dimroth P, Schink B (1998) Energy conservation in the decarboxylation of dicarboxylic acids by fermenting bacteria. Arch Microbiol 170:69–77CrossRefPubMed Dimroth P, Schink B (1998) Energy conservation in the decarboxylation of dicarboxylic acids by fermenting bacteria. Arch Microbiol 170:69–77CrossRefPubMed
48.
go back to reference Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–177CrossRefPubMed Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–177CrossRefPubMed
49.
go back to reference Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203CrossRefPubMed Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197–1203CrossRefPubMed
Metadata
Title
Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects
Authors
Joseph Okombo
Michael Liebman
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 3/2010
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0262-9

Other articles of this Issue 3/2010

Urolithiasis 3/2010 Go to the issue